Postmeningitic pediatric hearing loss from non-type b Haemophilus influenzae

Brian W Herrmann1, Salina H Goff2, Juri Boguniewicz3

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, United States of America; Children's Hospital Colorado, United States of America.

PubMed
Abstract

Insights

Non-typeable Haemophilus influenzae (nHIB) meningitis can cause temporary or permanent hearing loss in children. Steroid treatment may protect hearing, but more research is needed to understand outcomes.

Area of Science:

  • Pediatric Infectious Diseases
  • Otolaryngology
  • Neurology

Background:

  • Postmeningitic hearing loss is increasingly linked to non-typeable Haemophilus influenzae (nHIB) strains, not just Hib.
  • Pediatric hearing loss following nHIB H. influenzae meningitis is not well-documented.

Purpose of the Study:

  • To describe hearing outcomes in children with nHIB H. influenzae meningitis.
  • To investigate the potential otoprotective effect of steroids in nHIB H. influenzae meningitis.

Main Methods:

  • Retrospective case series of nHIB H. influenzae meningitis at Children's Hospital Colorado (2000-2020).
  • Literature review on nHIB H. influenzae and postmeningitic hearing loss.

Main Results:

  • Eleven pediatric cases of nHIB H. influenzae meningitis identified (serotypes f, a, and non-typable).
  • 40% of patients had initial hearing loss; outcomes ranged from recovery to profound sensorineural hearing loss requiring cochlear implantation.
  • Children with hearing loss also experienced intracranial sequelae like empyema, sinus thrombosis, and seizures.
  • Steroid use was associated with a lower incidence of initial hearing loss (25% vs. 66%).

Conclusions:

  • nHIB H. influenzae meningitis can lead to transient and permanent hearing loss.
  • Steroids may offer otoprotection, similar to Hib meningitis.
  • Further research is required to fully understand hearing outcomes after nHIB H. influenzae meningitis.